Summary
This multiancestry genome-wide association study identified genetic loci associated with unexplained chronic ALT elevation as a biomarker for nonalcoholic fatty liver disease, with findings validated against histological and radiological assessments. The work represents a large collaborative effort to map genetic susceptibility to NAFLD across diverse populations, as suggested by the involvement of the VA Million Veteran Program and multiple academic medical centres. The study contributes to understanding the heritable basis of NAFLD, a condition increasingly linked to metabolic and dietary factors.
UK applicability
The genetic findings may inform risk stratification and early detection of NAFLD in United Kingdom clinical populations, though ancestry-specific allele frequencies and effect sizes would require validation in UK cohorts. The study's identification of genetic drivers complements public health approaches to NAFLD prevention through diet and lifestyle modification in the NHS.
Key measures
Genetic variants (single nucleotide polymorphisms); ALT elevation; liver histology; radiological imaging; ancestry-stratified analyses
Outcomes reported
The study identified genetic variants associated with unexplained chronic ALT (alanine aminotransferase) elevation as a proxy for nonalcoholic fatty liver disease (NAFLD), validated against histological and radiological evidence. Findings were obtained across multiple ancestry groups to improve understanding of genetic risk factors for liver disease.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.